First human tests begin for new obesity shot
NCT ID NCT06577766
Summary
This is an early-stage study to test the safety and body processing of a new injectable medicine for people with overweight or obesity. Participants will receive either the new medicine or a placebo injection, and researchers will monitor for side effects. The main goal is to see if the medicine is safe and how it behaves in the body, not to measure weight loss.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
ICON
San Antonio, Texas, 78209, United States
Conditions
Explore the condition pages connected to this study.